Skip to main content
Ensysce Biosciences, Inc. (ENSC)
NASDAQ: ENSC · Real-Time Price · USD
0.579
-0.072 (-11.00%)
At close: Nov 4, 2024, 4:00 PM
0.595
+0.016 (2.78%)
Pre-market: Nov 5, 2024, 5:21 AM EST

Ensysce Biosciences Revenue

Ensysce Biosciences had revenue of $181.80K in the quarter ending June 30, 2024, a decrease of -62.93%. This brings the company's revenue in the last twelve months to $1.44M, down -51.96% year-over-year. In the year 2023, Ensysce Biosciences had annual revenue of $2.23M, down -11.61%.

Revenue (ttm)
$1.44M
Revenue Growth
-51.96%
P/S Ratio
2.11
Revenue / Employee
$205,419
Employees
7
Market Cap
8.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20232.23M-292.86K-11.61%
Dec 31, 20222.52M-1.01M-28.54%
Dec 31, 20213.53M-400.01K-10.18%
Dec 31, 20203.93M2.17M122.86%
Dec 31, 20191.76M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
XWELL 32.88M
Streamline Health Solutions 20.30M
Precipio 16.72M
Addex Therapeutics 960.64K
Soligenix 494.62K
Virax Biolabs Group 156.42K
Revenue Rankings

ENSC News

More News